Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stanley Venitt is active.

Publication


Featured researches published by Stanley Venitt.


Mutation Research | 1997

The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients

D.K. Scates; Allan D. Spigelman; Robin K. S. Phillips; Stanley Venitt

32P-postlabelling is a highly sensitive technique for the detection of DNA adducts. It is unique in that it requires no prior knowledge of the nature of adducts or adduct-forming species under investigation. In the past, we have used this technique to investigate the role of bile in the production of foregut adenomas in patients with familial adenomatous polyposis (FAP). We have found that bile contains constituents that form DNA adducts directly, and after metabolic activation, and that the bile of FAP patients has an increased capacity for adduct formation with DNA in vitro, in human cell lines in culture, and in the gastrointestinal tract of rats given bile by gavage. The sensitivity of 32P-postlabelling is such that it is difficult to obtain sufficient quantities of DNA adducts for chemical analysis. The nature of the adducts produced by bile, or of the bile constituents that produce them is as yet undetermined. In the present studies, we have combined 32P-postlabelling with indirect methods to gain some insight into the nature of DNA adducts produced by bile and the properties of the reactive species that form them. Firstly, bile was incubated with synthetic monodeoxynucleotides or polydeoxynucleotides. Bile did not produce adducts when incubated with monodeoxynucleotides or single-stranded polydeoxynucleotides. However, it did produce adducts when incubated with double-stranded polydeoxynucleotides. The pattern of adduct formation suggested that human bile forms a mixture of adenine and guanine adducts. Secondly, bile was fractionated by extraction with blue cotton or with neutral, acid or alkaline organic solvent. Blue cotton, which efficiently and selectively absorbs mutagens having 3 or more fused aromatic rings, did not absorb biliary constituents that could form adducts with DNA in vitro or with DNA of MCL-5 cells, a metabolically competent human cell line. This suggests that biliary DNA adduct precursors are polar compounds that contain fewer than 3 aromatic rings or are non-aromatic. Acidic organic extracts of human bile produced much higher levels of DNA adducts in vitro or with DNA of MCL-5 cells than did neutral or alkaline organic extracts, suggesting that constituents of bile that form DNA adducts are acidic in nature.


Carcinogenesis | 1992

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

Ian N.H. White; Francesco De Matteis; Adrian Davies; Lewis L. Smith; Christopher Crofton-Sleigh; Stanley Venitt; Alan Hewer; David H. Phillips


Carcinogenesis | 1999

Heterocyclic aromatic amines induce DNA strand breaks and cell transformation

Wolfgang Pfau; Francis L. Martin; Kathleen J. Cole; Stanley Venitt; David H. Phillips; Philip L. Grover; Hans Marquardt


Carcinogenesis | 1994

Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen

David H. Phillips; Gerard Andrew Potter; Martin N. Horton; Alan Hewker; Christopher Crofton-Sleigh; Michael Jarman; Stanley Venitt


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 1999

The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis (`comet') assay in metabolically-competent MCL-5 cells

Francis L. Martin; Kathleen J. Cole; Mariam H Orme; Philip L. Grover; David H. Phillips; Stanley Venitt


Cancer Research | 1996

Genotoxicity of Human Mammary Lipid

Francis L. Martin; Paul L. Carmichael; Christopher Crofton-Sleigh; Stanley Venitt; David H. Phillips; Philip L. Grover


Carcinogenesis | 1997

DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts

Francis L. Martin; Stanley Venitt; Paul L. Carmichael; Christopher Crofton-Sleigh; E M Stone; Kathleen J. Cole; Barry A. Gusterson; Philip L. Grover; David H. Phillips


Carcinogenesis | 1991

DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls

Allan D. Spigelman; D.K. Scates; Stanley Venitt; Robin K. S. Phillips


Journal of Medicinal Chemistry | 1998

Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.

Stanley Venitt; Christopher Crofton-Sleigh; Mavis Agbandje; Terence C. Jenkins; Stephen Neidle


The Lancet | 1994

Radon, mycotoxins, p53, and uranium mining

Stanley Venitt; PatrickJ. Biggs

Collaboration


Dive into the Stanley Venitt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francis L. Martin

University of Central Lancashire

View shared research outputs
Top Co-Authors

Avatar

Philip L. Grover

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

David Bosworth

Institute of Cancer Research

View shared research outputs
Top Co-Authors

Avatar

D.K. Scates

The Royal Marsden NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Allan D. Spigelman

University of New South Wales

View shared research outputs
Researchain Logo
Decentralizing Knowledge